Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAs

Table 1 Patient clinical characteristics

	n	Median (IQR)	p value*
Anthropometric
Sex (F, M)	93	71, 22	–
Age (year)	93	17 (3)	0.04
Height (cm)	93	164 (13)	0.3
Weight (kg)	93	126 (45)	0.36
BMI (kg/m²)	93	45.2 (13.2)	0.38
HDL function
Cholesterol efflux capacity	69	0.85 (0.17)	–
Lipid panel
Total cholesterol	69	127 (34)	0.89
LDL-C, mg/dL	69	77 (38)	0.86
HDL-C, mg/dL	69	40 (13)	0.11
Triglycerides	69	56 (36)	0.48
NMR spectroscopy
LDL particle concentration, nmol/L	69	933 (453)	0.15
HDL particle concentration, µmol/L	69	25.6 (5.3)	0.46
VLDL particle concentration, nmol/L	69	28.4 (20.4)	0.09
LDL particle size, nm	69	20.5 (9)	< 0.01
HDL particle size, nm	69	9.2 (0.7)	0.01
VLDL particle size, nm	69	48.4 (8.35)	0.17
Metabolic assessment
Lipoprotein insulin resistance score	69	46 (25)	0.45
Inflammation assessment
GlycA	69	429 (90)	0.15

Data are presented as Median (IQR). p value for Pearson product moment correlation coefficient for cholesterol efflux capacity

ISSN: 1479-5876